Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Anti-Cancer Drugs|April 9, 1999
Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]: mechanism of the selective action investigated on mouse tumorsG Sava, K Clerici, I Capozzi, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexesS Zorzet, A Bergamo, M Cocchietto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP sublineM Coluccia, G Sava, F Loseto, et al.
Archives of Biochemistry and Biophysics|March 24, 2000
DNA as a possible target for antitumor ruthenium(III) complexesE Gallori, C Vettori, E Alessio, et al.
Pathology Oncology Research : POR|April 29, 1998
Comparison of the effects of the antimetastatic compound ImH[trans-RuCl4(DMSO)Im] (NAMI-A) on the arthritic rat and on MCa mammary carcinoma in miceG Sava, R Gagliardi, M Cocchietto, et al.
International Journal of Oncology|May 17, 2011
Reduction of tumor-associated fibrinolytic-activity by antimetastatic dosages of 2 ru(ii)-dmso complexes in mice bearing lewis lung-carcinomaM Colucci, M Coluccia, P Montemurro, et al.
International Journal of Cancer|September 27, 1996
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complexG Sava, I Capozzi, A Bergamo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-AG Sava, A Bergamo, S Zorzet, et al.
Pageof 4